Harbin Medisan Pharmaceutical Co Ltd (002900) — Cash Flow-to-Debt Ratio
Harbin Medisan Pharmaceutical Co Ltd (002900) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-15.53 Million could theoretically repay 0% of its total liabilities (CN¥1.70 Billion) in one year. See 002900 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Harbin Medisan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Harbin Medisan Pharmaceutical Co Ltd across 13 annual periods. Also explore Harbin Medisan Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Harbin Medisan Pharmaceutical Co Ltd (2012–2024)
Year-by-year debt coverage analysis for Harbin Medisan Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is Harbin Medisan Pharmaceutical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | CN¥30.69 Million | CN¥1.64 Billion | ▼ -32.0% |
| 2023 | 0.03x | CN¥35.69 Million | CN¥1.29 Billion | ▼ -76.7% |
| 2022 | 0.12x | CN¥144.64 Million | CN¥1.22 Billion | ▲ +994.2% |
| 2021 | -0.01x | CN¥-12.53 Million | CN¥949.04 Million | ▼ -102.5% |
| 2020 | -0.01x | CN¥-4.51 Million | CN¥691.18 Million | ▼ -101.7% |
| 2019 | 0.39x | CN¥320.14 Million | CN¥820.44 Million | ▼ -27.4% |
| 2018 | 0.54x | CN¥292.46 Million | CN¥543.78 Million | ▼ -16.1% |
| 2017 | 0.64x | CN¥223.46 Million | CN¥348.80 Million | ▼ -0.8% |
| 2016 | 0.65x | CN¥231.18 Million | CN¥358.01 Million | ▲ +4.5% |
| 2015 | 0.62x | CN¥200.85 Million | CN¥324.95 Million | ▲ +92.0% |
| 2014 | 0.32x | CN¥116.31 Million | CN¥361.30 Million | ▼ -5.1% |
| 2013 | 0.34x | CN¥167.10 Million | CN¥492.63 Million | ▲ +3.6% |
| 2012 | 0.33x | CN¥123.22 Million | CN¥376.29 Million | — |